Comparative Effectiveness of Switching to Daptomycin Versus Remaining on Vancomycin Among Patients With Methicillin-resistant Staphylococcus aureus (MRSA) Bloodstream Infections | Zendy

Marin L. Schweizer | Zendy; Kelly Richardson | Zendy; Mary VaughanSarrazin | Zendy; Michihiko Goto | Zendy; Daniel J. Livorsi | Zendy; Rajeshwari Nair | Zendy; Bruce Alexander | Zendy; Brice Beck | Zendy; Michael Jones | Zendy; Mireia PuigAsensio | Zendy; Daniel Suh | Zendy; Michael Ohl | Zendy; Eli N. Perencevich | Zendy

Open Access

Comparative Effectiveness of Switching to Daptomycin Versus Remaining on Vancomycin Among Patients With Methicillin-resistant Staphylococcus aureus (MRSA) Bloodstream Infections

Author(s) -

Marin L. Schweizer,

Kelly Richardson,

Mary VaughanSarrazin,

Michihiko Goto,

Daniel J. Livorsi,

Rajeshwari Nair,

Bruce Alexander,

Brice Beck,

Michael Jones,

Mireia PuigAsensio,

Daniel Suh,

Michael Ohl,

Eli N. Perencevich

Publication year - 2020

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciaa1572

Subject(s) - daptomycin , medicine , vancomycin , methicillin resistant staphylococcus aureus , staphylococcus aureus , bacteremia , staphylococcal infections , confidence interval , surgery , antibiotics , microbiology and biotechnology , biology , bacteria , genetics

Patients with methicillin-resistant Staphylococcus aureus bloodstream infections (MRSA BSI) usually receive initial treatment with vancomycin but may be switched to daptomycin for definitive therapy, especially if treatment failure is suspected. Our objective was to evaluate the effectiveness of switching from vancomycin to daptomycin compared with remaining on vancomycin among patients with MRSA BSI.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research